Tenaya Therapeutics, Inc. Common Stock (TNYA) is a publicly traded Healthcare sector company. As of November 4, 2026, TNYA trades at $0.38 with a market cap of $82.12M and a P/E ratio of -1.09. TNYA moved +2.69% today. Year to date, TNYA is -49.20%; over the trailing twelve months it is -73.19%. Its 52-week range spans $0.35 to $2.35. Analyst consensus is strong buy with an average price target of $13.00. Rallies surfaces TNYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TNYA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.38 |
| Market Cap | $82.12M |
| P/E Ratio | -1.09 |
| EPS | $-0.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.35 |
| 52-Week Low | $0.35 |
| Volume | 1.56M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.33M |
| Net Income | $-103.11M |
| Gross Margin | 0.00% |
5 analysts cover TNYA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.00.